Concepedia

Maureen Caligiuri

MC

Statistics

Publications

16

Citations

1K

H-Index

15

Active since

1991

Affiliations

Forma Therapeutics (United States)(Current)

Cold Spring Harbor Laboratory

Howard Hughes Medical Institute

University of Virginia

Maureen Caligiuri is an author at Forma Therapeutics (United States) specializing in life sciences, enzyme inhibition, and molecular biology.

Publications per year

1991–2023

16

Publications

16

Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6

Nina Kerres, Steffen Steurer, Stefanie Schlager et al. · Cell Reports · 2017 · 206 citations · Full text

, , +11

Sct1 functions in partnership with Cdc10 in a transcription complex that activates cell cycle START and inhibits differentiation

Maureen Caligiuri, David Beach · Cell · 1993 · 113 citations

, , +16

Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors

Zhihong Lai, Tao Yang, Young B. Kim et al. · Proceedings of the National Academy of Sciences · 2002 · 106 citations

, , +15

Identification of amino acid residues involved in feedback regulation of the anthranilate synthase complex from Salmonella typhimurium. Evidence for an amino-terminal regulatory site

Maureen Caligiuri, Ronald Bauerle · Journal of Biological Chemistry · 1991 · 88 citations · Full text

, , +17

Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors

Xiaozhang Zheng, Paul Bauer, Timm Baumeister et al. · Journal of Medicinal Chemistry · 2013 · 81 citations · Full text

, , +17

1–5 of 16